Detalhe da pesquisa
1.
Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia.
N Engl J Med
; 386(15): 1421-1431, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35417637
2.
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.
Blood Adv
; 8(7): 1715-1724, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386978
3.
Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Case Rep Hematol
; 2021: 1717506, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34136291
4.
Detection of EBV DNA in Non-Hodgkin Lymphoma Patients in Bulgaria.
Indian J Hematol Blood Transfus
; 35(3): 465-470, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31388258